Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Endocrinology

Pharmacology/kinetics

Disease characteristics and outcomes in patients with chronic kidney disease and type 2 diabetes: A matched cohort study of spironolactone users and non-users

BMC Nephrology | Mar 07, 2020 Pharmacology/kinetics

Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?

Diabetes, Obesity and Metabolism | Mar 06, 2020 Pharmacology/kinetics

Race may not impact endocrine therapy-related changes in breast density

Cancer Epidemiology, Biomarkers & Prevention | Mar 05, 2020 Pharmacology/kinetics

The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial

Metabolism | Mar 04, 2020 Pharmacology/kinetics

Durability of glycaemic control in patients with type 2 diabetes after metformin failure: Prognostic model derivation and validation using the DISCOVER study

Diabetes, Obesity and Metabolism | Mar 04, 2020 Pharmacology/kinetics

Association of glucose-lowering medications with cardiovascular outcomes: An umbrella review and evidence map

The Lancet Diabetes & Endocrinology | Mar 04, 2020 Pharmacology/kinetics

Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: The DATA-HD RCT

Journal of Clinical Endocrinology & Metabolism | Mar 04, 2020 Pharmacology/kinetics

Relationship between hypoglycaemia, body mass index and quality of life among patients with type 1 diabetes: Observations from the DEPICT clinical trial programme

Diabetes, Obesity and Metabolism | Mar 02, 2020 Pharmacology/kinetics

Long-term (52-week) efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open-label extension of a phase III study

Journal of Diabetes Investigation | Mar 01, 2020 Pharmacology/kinetics

Influence of different treatment strategies on new-onset atrial fibrillation among patients with primary aldosteronism: A nationwide longitudinal cohort-based study

Journal of the American Heart Association | Feb 27, 2020 Pharmacology/kinetics

« Prev 1 … 30 31 32 33 34 … 122 Next »

Disease characteristics and outcomes in patients with chronic kidney disease and type 2 diabetes: A matched cohort study of spironolactone users and non-users

Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?

Race may not impact endocrine therapy-related changes in breast density

The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial

Durability of glycaemic control in patients with type 2 diabetes after metformin failure: Prognostic model derivation and validation using the DISCOVER study

Association of glucose-lowering medications with cardiovascular outcomes: An umbrella review and evidence map

Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: The DATA-HD RCT

Relationship between hypoglycaemia, body mass index and quality of life among patients with type 1 diabetes: Observations from the DEPICT clinical trial programme

Long-term (52-week) efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open-label extension of a phase III study

Influence of different treatment strategies on new-onset atrial fibrillation among patients with primary aldosteronism: A nationwide longitudinal cohort-based study

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

More Women Experience Chronic Pain Than Men: Find Out Why

Disease characteristics and outcomes in patients with chronic kidney disease and type 2 diabetes: A matched cohort study of spironolactone users and non-users

Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?

Race may not impact endocrine therapy-related changes in breast density

The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial

Durability of glycaemic control in patients with type 2 diabetes after metformin failure: Prognostic model derivation and validation using the DISCOVER study

Association of glucose-lowering medications with cardiovascular outcomes: An umbrella review and evidence map

Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: The DATA-HD RCT

Relationship between hypoglycaemia, body mass index and quality of life among patients with type 1 diabetes: Observations from the DEPICT clinical trial programme

Long-term (52-week) efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open-label extension of a phase III study

Influence of different treatment strategies on new-onset atrial fibrillation among patients with primary aldosteronism: A nationwide longitudinal cohort-based study

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

More Women Experience Chronic Pain Than Men: Find Out Why

Select Specialty

Select Topic